Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials

Lopinavir/ritonavir (LPV/r) is the first ritonavir-boosted protease-inhibitor used in second-line anti-retroviral treatment (ART) in resource-limited regions. To evaluate the efficacy and safety outcomes of LPV/r in treatment-naïve and -experienced HIV-infected adults and pregnant women, we performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaojie, Xu, Yuanlong, Yang, Qiuying, Chen, Jieqing, Zhang, Tong, Li, Zaicun, Guo, Caiping, Chen, Hui, Wu, Hao, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336931/
https://www.ncbi.nlm.nih.gov/pubmed/25704206
http://dx.doi.org/10.1038/srep08528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336931/
https://www.ncbi.nlm.nih.gov/pubmed/25704206
http://dx.doi.org/10.1038/srep08528

Ejemplares similares